Specifically, substantial foundational cellular and animal studies indicate that the immune checkpoint proteins such as CTLA-4, PD-1, PD-L1, and LAG-3 serve as crucial negative regulators of atherosclerosis (176–178). This evidence concerns the gene CTLA4 and atherosclerosis.